PINL:GRPOF - Post by User
Comment by
frobin2on Aug 08, 2018 3:04pm
![](https://assets.stockhouse.com/kentico-cms/0342-00/images/Sprite.svg#id_Post_Views_Icon)
127 Views
Post# 28429039
RE:RE:RE:RE:RE:I’m going to say
RE:RE:RE:RE:RE:I’m going to sayLeafRider wrote: MoeMoney101 wrote: This stock is going to surge beyond 5$ by Dec/2018/
You very well could be right. The more chart based mark highlights that once we break $1.75 we could be on our way to at least $2.30, and honestly all it's going to take is a successful phase 3 clinical trial for PPP001 and Health Canada approval for official "drug status". One must think that buyers are lined up for an offer once the phase 3 clinical data is available!
Who is going to bid more Canopy or Aphria? Aphria passed on Hiku Brands, so maybe Aphria and Canopy go after Tetra a little more agressively. Only time will tell, maybe Big Pharma trumps everyone and takes a big swing at us. Let's see +$5 at the time of buyout at the very least!!
Great question - APH already owen 17% of TBP, and Canopy has acquired Canopy Health Innovations. While APH wouldn't want to give up their share in TBP, I could see Canopy trying to snag them for sure!